Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study.

about

Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study.

Item

http://www.wikidata.org/entity/Q55379237

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Treatment patterns and outcome ...... pulation-based outcomes study.

@en

Treatment patterns and outcome ...... pulation-based outcomes study.

@nl

type

Item

label

Treatment patterns and outcome ...... pulation-based outcomes study.

@en

Treatment patterns and outcome ...... pulation-based outcomes study.

@nl

prefLabel

Treatment patterns and outcome ...... pulation-based outcomes study.

@en

Treatment patterns and outcome ...... pulation-based outcomes study.

@nl

P1476

Treatment patterns and outcome ...... opulation-based outcomes study

@en

P2093

Jee Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Jeong-Ok Lee

http://www.w3.org/2001/XMLSchema#string

Ji Yun Lee

http://www.w3.org/2001/XMLSchema#string

Ji-Won Kim

http://www.w3.org/2001/XMLSchema#string

Jong Seok Lee

http://www.w3.org/2001/XMLSchema#string

Ju Hyun Lee

http://www.w3.org/2001/XMLSchema#string

Koung Jin Suh

http://www.w3.org/2001/XMLSchema#string

Mihong Choi

http://www.w3.org/2001/XMLSchema#string

Se-Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Soo-Mee Bang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2012

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer.

Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatin.

Modified FOLFOX-6 therapy for heavily pretreated advanced gastric cancer refractory to fluorouracil, irinotecan, cisplatin and taxanes: a retrospective study.

Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer.

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer.

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014

P304

e0198544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0198544

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29879177

http://www.w3.org/2001/XMLSchema#string

P932

5991719

http://www.w3.org/2001/XMLSchema#string